and development for infertility.
reviewing and commenting on the scant literature available. The objectives of this study were to estimate the direct More challenging is an alternative strategy with the following cost of infertility management, including diagnosis and objectives: (i) to estimate from various sources of existing treatment, in Canada during 1995, and the relative cost information the overall direct cost of infertility management per live birth by treatment category. The analysis was in a single country (in this case, Canada) for a single year based on the following estimates: the prevalence of (1995) and (ii) to estimate average cost-outcome ratios for the infertility in Canada in 1995; the volume and distribution treatments that are pertinent to each infertility diagnostic of infertility services; and the effectiveness and cost of category. specific infertility treatments. In 1995 there were~330 000
The estimate for objective (i) will include costs covered by couples experiencing infertility in Canada. It is estimated provincial health care plans and drug insurance plans, and also that Ͻ50% (150 000) sought medical advice or treatment costs for treatment paid by the patients receiving the services. during that year. A total of 13 diagnostic and treatment Not included are costs to the patient such as transport to the categories account for nearly all of the treatments received, clinic, accommodation or time off work, medical costs due to and these categories form the treatment model. The cost complications of treatments (e.g. ovarian hyperstimulation of treatment per live birth ranges from Cdn$650 for syndrome) or costs to the patient or the health care system clomiphene treatment of unexplained infertility to accrued during pregnancy, delivery or the neonatal period. It Cdn$41 000 for in-vitro fertilization. For a hypothetical is accepted that infertility treatment may result in a higher group of 100 couples, the annual cost of diagnosis and than average proportion of multiple births. However, the treatment would be Cdn$77 000 and Cdn$200 000 respectadditional costs of premature births resulting from multiple ively for a total of Cdn$277 000, or an average of Cdn$2770 gestation are not included here. The final estimate of infertility per couple. After 1 year of treatment, it is expected that management costs will be compared with the total annual 26 of these 100 couples would achieve a live birth. The health care expenditure in Canada to put into perspective the total annual cost of infertility management in Canada, issue of infertility treatment cost. estimated to be~Cdn$415 million, is 0.6% of the annual For the second objective, we will determine the direct cost cost of health care.
of conceiving a pregnancy which results in a live birth in Key words: cost analysis/effectiveness/infertility treatment/ couples who have consulted a physician regarding infertility. utilization This cost will vary depending on the treatment received, which in turn depends on the reason for infertility. The analysis assumes that for fertile couples there is no cost involved in conceiving a child. Therefore any medical assistance provided Introduction to infertile patients or any expenditure by the patients themselves is an extra cost to society. To make decisions about In recent years, public attention has been focused on issues surrounding assisted reproductive technology for the treatinfertility services it is necessary to be aware not only of their costs but also of their usefulness in leading to the goal of ment of infertility, and in particular the cost of such treatment. In-vitro fertilization (IVF) and other new health technologies infertility treatment, i.e. the live birth of a healthy infant. The information required for the analysis includes estimates are expensive because they require highly trained personnel, costly drugs, expensive equipment and frequent monitoring of: (i) the prevalence of infertility in Canada in 1995; (ii) the volume and distribution of infertility services; (iii) the costs (US Congress, Office of Technology Assessment, 1988) . The cost of IVF in Canada ranges from Cdn$1800 to $4600 per of specific infertility diagnostic and treatment protocols; and (iv) the effectiveness of specific infertility treatments. Estimates cycle, plus the cost of medications which average Cdn$1500-2500 (Fluker and Tiffin, 1996) . of the cost of medical services that are not based on actual expenditures necessarily entail assumptions concerning cost, Few studies, however, address the overall direct cost of infertility management, which includes both diagnosis and effectiveness and utilization. Uncertainties about the level of more than guestimates of the real expenditures.
Number of couples
In the 1991 Canadian census there were 3.6 million couples of
Materials and methods
whom the female partner was aged 18-44 years and who had been married or co-habiting for at least 1 year. From 1991 to 1995 the The prevalence of infertility in Canada in 1995 total population of Canada increased by 8.2%; thus the estimate of Proportion of couples such couples for 1995 would be 3.9 million. The estimate of the The Royal Commission on New Reproductive Technologies (RCNRT) number of infertile couples in Canada in 1995 is 8.5% of this figure, estimated the prevalence of infertility in Canada from three telephone or~330 000 couples. surveys conducted across Canada in late 1991 and early 1992, which included a total of 1412 respondents. The denominator was all women
The volume and distribution of infertility services in Canada aged 18-44 years who had been married or co-habiting for at least 1 year. A woman was classified as infertile if she responded Volume of services that she had not used contraception in the past 12 months, that neither
The proportion of infertile couples in Canada who seek medical care she nor her partner had been surgically sterilized, and that she had has not been assessed in a formal manner. Although care-seeking not been pregnant in the past 12 months. All three surveys yielded behaviour may not be similar in Canada and the USA, the proportion similar results, which is an indication that the estimate is reliable.
of infertile couples is highly comparable, and this may excuse the The combined results showed that 8.5% of such couples were use of estimates from the USA. The NSFG survey estimated that experiencing infertility at the time of the survey. The 95% confidence 2.3% of all American women of reproductive age receive medical interval for the estimate was 7.0-9.9% (RCNRT, 1993) . This was not advice or treatment for infertility in a given year (Mosher and Pratt, an estimate of the proportion of couples who would experience 1991). The female population of Canada aged 15-44 years was 6.5 infertility in their lifetime, but rather an estimate of the proportion million in 1995, of which 2.3% is~150 000. Assuming that the of couples of reproductive age who were currently aware that they number of women seeking infertility services who are not in the cowere having difficulty conceiving, and who may potentially seek habiting, 18-44 year old age group is negligible, this would mean medical assistance to achieve pregnancy. that 45% of infertile couples sought medical assistance to achieve Comparison with estimates in the USA pregnancy in 1995. The prevalence of infertility in the Canadian RCNRT survey was Distribution of diagnostic services virtually the same as the estimate in the USA, although the Of those couples who seek medical assistance for their infertility, the methodology was slightly different. Using the methods of the proportion who would be expected to receive the most commonly National Study of Family Growth (NSFG) in the USA, the 1 year provided diagnostic services over the course of a year are shown in figure for Canada in 1991-1992 was 8.0% of currently married or Table I . These estimates are based on data from 2198 couples seen co-habiting couples with a female partner aged 18-44 years (RCNRT, in Canadian fertility clinics from 1984 to 1991 during the Canadian 1993). For the USA in 1988, the 1 year estimate for the prevalence Infertility Treatment Evaluation Study (CITES; Collins et al., 1993) . of infertility was 7.9% of currently married couples with a female
The distribution of diagnostic services in 1995 is not expected partner aged 15-44 years (Mosher and Pratt, 1990) .
to differ greatly from the CITES figures. It is assumed that all This comparison of estimates for Canada and the USA is useful patients seeking medical assistance first see their family physician or for two reasons. First, to project the 1991 Canadian prevalence gynaecologist, who would carry out only basic diagnostic assessments. estimate to 1995 we assume that it is stable over time. Because the Because 82% of CITES patients underwent either a diagnostic RCNRT survey was the first to estimate reliably the prevalence of laparoscopy or a treatment usually available only in a fertility clinic, infertility in Canada, data to support this assumption are not available.
this figure was used, in the absence of more precise data, as the However, the estimates of infertility for the USA were stable from estimate for the proportion of couples who are referred to a fertility 1965 to 1988 (Mosher and Pratt, 1990) . Comparable prevalence specialist for further work-up. Couples having diagnostic tests would estimates in 1991 for the USA and Canada support the assumption that the prevalence of infertility is also stable in Canada. Second, to return at least once to the specialist to discuss test results and plan care. 
Distribution of treatment services
The distribution of treatments among couples using fertility services was also estimated from CITES. This study reflected the treatment choices of couples with an average 3.5 years' duration of infertility and a mean female age of 29.5 years, all of whom were attending specialized clinics (Collins et al., 1993) . Table II shows the distribution of their initial treatment choices. Because the CITES treatment choices in 1984-1991 may not reflect the choices in 1995, in particular the use of human menopausal gonadotrophins (HMG) for ovulation induction with intrauterine insemination (IUI) of partner's spermatozoa, which has recently become more widely available, the latter treatment replaces the 'other' treatment category for the projected 1995 distribution of treatments (Table II and Figure 1 ). The infertility diagnostic category that would apply to each treatment is also given in Table II . During a single year, some couples will undergo more than one treatment. In the CITES data, 6.5% of patients received a second treatment within 1 year. The effect of these additional treatments on live birth is inconsequential, because couples will only move on to a second treatment if the first has been unsuccessful, but the effect on costs may be considerable. Thus, the cost calculations below account for the cost of a second treatment within 1 year by adding 5% to the cost of each treatment.
The effectiveness of infertility treatment
For the purpose of estimating effectiveness, the commonly used Figure 1 . Comparison of the percentage of infertility patients in treatments shown in Table II were grouped by primary diagnosis each diagnosis/treatment group (hatched bars) and the cost per live because the reason for the infertility has an effect on success rate. birth for each group (solid bars). CC ϭ clomiphene citrate; The group of couples who received only advice and/or diagnosis Ovul ϭ ovulation defect; UI ϭ unexplained infertility; were considered to be untreated or 'self-treated', because it is assumed Endo ϭ endometriosis; OvSup ϭ ovulation suppression; that they continued to attempt pregnancy, and would include those Tubl ϭ tubal factor; Male ϭ male factor; PI ϭ persistent infertility. with all diagnoses of infertility. Effectiveness was estimated with See also footnote to Table III . $ are Cdn$. respect to live birth rate, which is the most relevant outcome. However, in most published studies pregnancy rate is reported. These rates were converted to live birth rates using the proportion of live treatment protocol to yield the live birth rates per patient per annum. Typical durations of therapy for cyclical treatments were drawn from births observed among pregnancies in CITES (86%; Collins et al., 1995) . Table III specifies the diagnosis and treatment groupings and a description of treatment in CITES (Collins et al., 1993) . For example, in the clomiphene trials for unexplained infertility, the summarizes the published evidence on effectiveness.
The live birth rates given in Table III are the aggregates of the aggregate pregnancy rate per cycle was 6.8%, which converts to a 6.8ϫ0.86 ϭ 5.8% live birth rate per cycle of treatment. The typical pregnancy rates per cycle in the reported trials, multiplied by the live birth factor (0.86). These were multiplied by the duration of each duration of this treatment was 6 months, taking into account any HMG ϭ human menopausal gonadotrophin; IUI ϭ intrauterine insemination; IVF ϭ in-vitro fertilization; TDI ϭ therapeutic donor insemination. a Collins et al. (1995) . b ESHRE Capri Workshop (1996) . c Taylor and Collins (1992) . d Adamson and Pasta (1994) . e Byrd et al. (1990) ; Odem et al. (1991) ; Patton et al. (1992) ; Robinson et al. (1992) ; Subak et al. (1992) . f International Working Group for Registers on Assisted Reproduction (1995). shorter duration of use due to conceptions and any longer use among dollars with the use of the inflation factor for health care costs in Canada for December 1995 (Statistics Canada, 1996) . some patients. Thus the expected probability of live birth for this therapy per annum was 5.8ϫ6 ϭ 35.0%. In the case of non-cyclical
Cost of advice and diagnosis therapy, such as surgery or ovulation suppression, live birth rates These costs are summarized in Table I . The costs for physician visits were estimated for the first year after completion of the intervention. and diagnostic tests were taken from the 1995 Ontario fee schedule. Table III summarizes the live birth rates per cycle, the typical number
The average cost of advice and diagnosis per patient is estimated to of cycles per treatment and the expected live birth rate per patient be Cdn$770. per year.
Self-treatment costs
No published estimate could be found for the amount spent by The cost of infertility services patients who decide not to undergo treatment after being assessed. Only direct costs were included in the analysis, as discussed in Expenditures are routinely made, however, to buy thermometers or Introduction. When nationally representative, published cost estimates test kits, for example. Lacking any information on the extent of these were not available, known costs were used from Chedoke-McMaster costs, it was assumed that couples who are not undergoing treatment Hospital (CMH), Hamilton, Ontario, Canada. With respect to costs protocols spend Cdn$20 per month or Cdn$240 per annum on to consumers, Hamilton is near the median among Canadian cities.
infertility-related items. Therefore it is perhaps plausible that the same is true for health care costs. The costs were derived for individual diagnostic tests and
Clomiphene costs
No published estimate could be found. The estimate shown (Cdn$229) treatments as described below, and these are summarized in Tables I  and IV 
HMG costs
A published estimate of the 1994 cost of HMG/IUI was US $1200,
Results
or Cdn$1680 per treatment cycle (Peterson et al., 1994) . This cost included clinic visits, procedures, monitoring and medications, and
The cost of diagnosis for 100 couples was calculated to be applied to women of all diagnostic categories. About half the women~$ 77 000 (Table I) . A summary of treatment costs for 100 with ovulation defects who are treated with HMG are more difficult couples is shown in Table V . The cost per treatment from to stimulate and were considered to require three additional ampoules Table IV was multiplied by the proportion of patients receiving of medication and two additional clinic visits ($250). Subtracting IUI that treatment from Table II , and these were summed to costs (estimated below), the HMG costs for women with ovulation estimate the total annual cost of infertility treatment in a defects would be $1600 per cycle.
hypothetical group of 100 couples. When the 5% adjustment depending on product and dosage. The average was taken to be $300
The cost per live birth for the various treatments is shown per month, and the final estimate included one physician visit ($19) in Table IV In Table V (Fluker and Tiffin, 1996) , which included the costs of during 1 year was just under 26. Figure 2 shows the percentage screening and testing donors and laboratory charges for freezing, of total births that resulted from each treatment within a thawing and processing spermatozoa. The estimate of $354 per cycle diagnostic group. The live birth rate per patient was only 14% was the sum of this fee, the LH test kit cost ($50), procedure fees for self-treatment (Table III) , but 40 of the 100 couples were ($24) and ambulatory facility charges ($30). in this category, so it accounted for 0.14ϫ40 ϭ 5.6 births per Male treatment costs annum, which was 22% of the 26 live births in the hypothetical No published estimate could be found. Clomiphene (25 mg/day) cohort. In contrast, although the live birth rate was much appears to be the most frequent treatment, usually for 3 months.
higher (43%) for three cycles of HMG treatment for ovulation Typical costs were $95 per month for drugs and dispensing fees, and defects, only two of the 100 couples received this treatment, one physician visit ($19), giving a total of $304. so it accounted for only 0.8 or 3% of the live births per annum IVF costs in 100 patients.
Charges for IVF in Canadian centres in 1995 ranged from $1800 to Similarly, the cost of each treatment in a group of 100 $4620 per cycle (Fluker and Tiffin, 1996) . The median cost of $3800 infertile couples divided by the total cost ($200 000) gave the (including clinic visits, injections, medications, monitoring, physician percentage of the total cost attributable to each treatment fees and laboratory and hospital charges), combined with an estimated average cost of $1900 for medications, provided the cost estimate within a diagnostic group (Figure 2 ).
for one cycle of IVF of $5700.
Cost per live birth

Discussion
The costs of infertility treatment for the various diagnostic categories
In this model of infertility diagnosis and treatment in Canada and treatments are summarized in Table IV (Collins et al., 1995) . It is of cycles that resulted in live births. For example, clomiphene treatment for unexplained infertility had a cost of $229 per patient also higher than the rates in similar published follow-up from patients with a long duration of infertility (Collins et al., 1995) . Compared with the estimates for live birth rates, more assumptions about costs were necessary because of missing information, and this could have affected the validity of the cost calculations. The costs attributed to the self-treated group are notional, and the costs of many treatments have not been formally assessed. It was also necessary to use local costs for some treatments such as IUI. Nevertheless, for the most expensive therapies (HMG and IVF) the cost estimate could be based on recently published figures (Peterson et al., 1994; Fluker and Tiffin, 1996) .
With respect to the IVF data, we elected to make use of published figures for IVF success rates with fresh embryo transfer only, because the detailed cost analysis was based on this treatment. By 1995, embryo cryopreservation was available in all Canadian centres. This technique was forecast to increase live birth rates per stimulation cycle by an estimated 1.8% (Daya et al., 1995) . IVF costs per cycle and per live birth, including embryo cryopreservation, were given by Daya et al. (1995) . The cost per live birth in that paper (Cdn$35 000) was lower than the present estimate because of this inclusion of cryopreservation successes and the effects of inflation. Natural cycles were not considered here because our centre was estimates for intracytoplasmic sperm injection (ICSI) because data on utilization in Canada and success rates are not yet studies, but all of these reports were based on patients attending available. Nevertheless, the live birth rates and costs for ICSI specialized clinics (Collins et al., 1984; Dunphy et al., 1989;  are probably similar to those for IVF, and would be included Bostofte et al., 1993; Eimers et al., 1994) . Such patients have in our analysis as treatment for persistent infertility. a longer duration of infertility and lower fertility than the It can be argued that an analysis of the cost of infertility average infertile couple. Therefore the model appears to be treatment should include costs of the complications and consistent with published empirical observations. consequences of that treatment, such as ovarian hyperThe live birth rates for the various treatments used in the stimulation syndrome, ectopic pregnancy, miscarriage and model were derived primarily from trial results, and thus are premature delivery due to multiple gestation. Neumann et al. the most accurate estimates available. However, the untreated (1994) concluded that these factors added 21% to the base cost of an IVF cycle, which for our estimate would be live birth rate may be underestimated because it was derived
Cost of infertility treatment in Canadã
Cdn$1200. Taking into account treatment-related maternal alternative model could assume that the proportion of patients receiving IVF is 4%, as reported for the USA in the NSFG, complications only, they estimated a 2% increase in cycle cost. If we added either of these increments to the cycle cost of rather than 6%, and that the proportion receiving HMG/IUI treatment is 4% rather than 8% (Wilcox and Mosher, 1993) . IVF, we would have to similarly increase the cost of all the other treatments. However, because the data are not available
The 6% of couples who would not be allocated in this model could be assumed to receive a variety of other treatments for all treatments, we have chosen not to include these extra costs in our analysis. On the other hand, neither have we having an aggregate of the average cost per patient for all treatments except HMG/IUI and IVF. In this alternative included possible savings and benefits to society attributable to fertility treatment.
model the total cost of treatment for 100 couples, adjusted for repeated treatments, would be~Cdn$162 000 rather than Costs and outcomes are important factors that influence clinical decisions, and it would be inappropriate to isolate Cdn$200 000, a reduction of 19%. The overall cost of infertility diagnosis and treatment in Canada would be Cdn$359 million costs from effectiveness. The overall cost of infertility treatment was derived from estimates of the cost of each treatment and rather than Cdn$415 million. With the treatment distribution assumptions for this model, the aggregate birth rate would be the number of infertile couples making use of each service. In a parallel fashion, the overall success of infertility treatment reduced by only 0.6% to 25.2%. It seems clear that the model presented in Results, based as it is on the treatment experience was derived from estimates of the effectiveness of each treatment and the number of infertile couples making use of in advanced infertility clinics, yields a cost estimate which is at the higher end of the likely range of true costs for infertility each service. Thus it is appropriate to compare the proportion of cost and the proportion of births associated with a given treatment in Canada. Differences in the order of Cdn$56 million arising from a change in the assumptions for a single treatment (Figure 2 ). It is obvious that the proportion of costs does not always correspond to the proportion of live births. diagnostic category should not distract attention from the usefulness of the original model, if only because there is little For example, both clomiphene and IUI are used for the treatment of unexplained infertility, contributing about equally information about the overall cost of infertility management in the public domain. to the cost of infertility treatment (1.2 and 1.1% respectively). However, clomiphene treatment results in 14% of live births,
The estimates of cost per live birth provided in Table IV are quite crude and are not a substitute for a careful economic while IUI results in only 2%. Self-treatment is associated with just 5% of total costs but contributes 22% of live births, evaluation of each of the services listed. At best these are estimates of the average cost per live birth. These average cost in part because it is the largest category. On the other hand, HMG/IUI and IVF treatments for persistent infertility together figures do not provide information comparing the incremental cost of one clinically relevant treatment plan relative to the account for 57% of the total treatment costs but result in just over 18% of the live births, in part because patients in this cost of a clinically relevant alternative plan for the same indication. In addition, the estimates do not take into account category are the most difficult to treat.
The distribution of treatment services used in the model any systematic difference among categories in the 'quality' of the live births, such as the incidence of multiple pregnancies was based on the treatment choices of CITES couples, who may not be typical of infertile couples in general. However, and prematurity. The descriptive information provided in Table  IV is not meant to be used as if it were evaluative information the proportion who visited a physician and, after discussion and perhaps some diagnostic tests, decided not to have any such as the information available for IVF Neumann et al., 1994) . treatment was similar in CITES (40%) and in the American NSFG survey (43%), which included visits to family physicians What is the context for health expenditures in the order of Cdn$400 million? Total health care spending in Canada is (Wilcox and Mosher, 1993) . A recent unpublished survey of 1500 Canadian family physicians found that clomiphene was estimated to be Cdn$74 billion for 1995, of which~72% was publicly funded. The cost of infertility management is~0.5-prescribed on a regular basis by 11% of respondents and occasionally by 34%, but other types of infertility treatment 0.6% of the Cdn$74 billion total. In comparison, health care spending for the treatment and care of patients with were rarely used. A companion survey of 500 Canadian obstetricians/gynaecologists found that 88% may prescribe osteoporosis in Canada amounts to~Cdn$1.3 billion annually or 1.8% of total health care costs (Goeree et al., 1996) . The clomiphene for their infertile patients, but only 15-20% offered more complex treatments such as ovulation induction with average annual cost per patient treated for osteoporosis is Cdn$17 000, compared with Cdn$2700 per couple for infertil-HMG or artificial insemination with partner's or donor spermatozoa (S. Daya, personal communication) . Therefore, ity management. Unquestionably, infertile couples and their clinicians put a it seems that the majority of infertility treatments are provided by fertility clinics or specialists, justifying the use of the high value on infertility diagnosis and treatment services. The funding of health programmes, however, is also influenced by CITES figures as the best available data for estimating the distribution of treatment services.
societal attitudes and the views of politicians and health administrators who may not be as sensitive to the burden of Any misjudgement about the proportion of couples undergoing HMG/IUI or IVF treatment would not alter the high infertility as a health disorder. One implication of the results of this study is that the majority of the cost of infertility cost-outcome ratio for these categories, but it could have a marked effect on the total cost per 100 couples and on the treatment arises from the diagnostic categories that are the most difficult to treat. estimate of the overall costs in Canada. For example, an
